VEGFA and neoplasm: In the diagnosis of metastatic colorectal cancer, for example, VEGF inhibitors Bevacizumab, the FDA-approved antiangiogenic monoclonal antibody (mAb), capable of restoring irregular tumor vessel configuration to a more natural phenotype, is added (Kong et al., 2017).